Platelet-enriched plasma and muscle strain injuries: Challenges imposed by the burden of proof

Clinical Journal of Sport Medicine

Volumn 21, Issue 1, 2011, Pages 31-36

  Hamilton, Bruce H ^a   Best, Thomas M ^b  

^a ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

autologous plasma; muscle injury; platelet enriched plasma; platelet rich plasma

Indexed keywords

ARTICLE; ATHLETE; BLOOD AUTOTRANSFUSION; EVIDENCE BASED MEDICINE; HEALTH CARE UTILIZATION; HUMAN; MUSCLE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPORT; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

BLOOD TRANSFUSION, AUTOLOGOUS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED PRACTICE; HUMANS; INJECTIONS, INTRAMUSCULAR; MUSCLE, SKELETAL; PLATELET-RICH PLASMA; SPRAINS AND STRAINS; TREATMENT OUTCOME;

EID: 78651395469     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e318205a658     Document Type: Article

References (75)

1. Orchard JW. Intrinsic and extrinsic risk factors for muscle strains in Australian football. Am J Sports Med. 2001;29:300-303.
2. Orchard J, Marsden J, Lord S, et al. Preseason hamstring muscle weakness associated with hamstring muscle injury in Australian footballers. Am J Sports Med. 1997;25:81-85.
3. Jarvinen T, Kaariainen M, Jarvinen M, et al. Muscle strain injuries. Curr Opin Rheumatol. 2000;12:155-161.
4. Engebretsen A, Myklebust G, Holme I, et al. Intrinsic risk factors for hamstring injuries among male soccer players. A prospective cohort study. Am J Sports Med. 2010;38:1147-1153.
5. Orchard J, Best TM, Mueller-Wohlfart H-W, et al. The early management of muscle strains in the elite athlete: best practice in a world with a limited evidence basis. Br J Sports Med. 2008;42:158-159.
6. McCrory P, Franklyn-Milller A, Etherington J. Sports and exercise medicine - new specialists or snake oil salesmen? [published online ahead of print November 29, 2009]. Br J Sports Med. doi:10.1136/bjsm.2009.068999.
7. Sanchez M, Anitua E, Orive G, et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39:1-10.
8. Kasemkijwattana C, Menetrey J, Somogyi G, et al. Development of approaches to improve the healing following muscle contusion. Cell Transplant. 1998;7:585-598.
9. Kasemkijwattana C, Menetrey J, Bosch P, et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop Relat Res. 2000; 370:272-285.
10. Menetrey J, Kasemkijwattana C, Day C, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg. 2000;82:131-137.
11. Foster TE, Puskas B, Mandelbaum B, et al. Platelet-rich plasma. From basic science to clinical applications. Am J Sports Med. 2009;37: 2259-2272.
12. M-Dan O, Mann G, Maffulli N. Platelet-rich plasma: any substance into it? Br J Sports Med. 2010;44:618-619.
13. Schwarz A. A Promising Treatment for Athletes, in Blood. New York Times. February 16, 2009:A1.
14. Naturopathic doctor of Scottsdale treats golf injuries with revolutionary technology. Newsguide.us Web site. 2010. http://newsguide.us/index. php?path=/health-medical/alternative-medicine/Naturopathic-Doctor-of- Scottsdale-Treats-Golf-Injuries-with-Revolutionary-Technology/. Accessed April 13, 2010.
15. Cook J. Funky treatments in elite sports people: do they just buy rehabilitation time? Br J Sports Med. 2010;44:221.
16. Anitua E, Sanchez M, Orive G, et al. Delivering growth factors for therapeutics. Trends Pharmacol Sci. 2007;29:37-41.
17. Anitua E, Sanchez M, Orive G, et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28:4551-4560.
18. Everts P, Hoffmann J, Weibrich G, et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med. 2006;16:363-368.
19. Wright-Carpenter T, Klein P, Schaferhoff P, et al. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med. 2004;25: 588-893.
20. Sanchez A, Anitua E, Andi I. Application of autologous growth factors on skeletal muscle healing. Oral presentation at: 2nd World Congress on Regenerative Medicine; May 18-20, 2005; Leipzig, Germany.
21. Loo W, Lee D, Soon M. Plasma rich in growth factors to treat adductor longus tear. Ann Acad Med. 2009;38:733-734.
22. Wright-Carpenter T, Opolon P, Appell HJ, et al. Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med. 2004;25: 582-587. (Pubitemid 39518135)
23. Carda C,Mayordomo E, EncisoM, et al. Structural effects of the application of a preparation rich in growth factors onmuscle healing following acute surgical lesion Paper presented at: 2nd International Conference on Regenerative Medicine; May 18-20, 2005; Leipzig, Germany.
24. Hammond J, Hinton R, Curl L, et al. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med. 2009;37:1135-1142.
25. Charge S, Rudnicki M. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004;84:209-238.
26. Nurden A. Platelets and tissue remodeling: extending the role of the blood clotting system. Endocrinology. 2007;148:3053-3055.
27. Klinger M, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22:913-922.
28. Rendu F, Brohard-Bohn F. The platelet release reaction: granules'constituents, secretion and functions. Platelets. 2001;12:261-273.
29. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009;23:177-189.
30. Italiano J, Battinelli E. Selective sorting of alpha-granule proteins. J Thromb Haemost. 2009;7:173-176.
31. Ciferri S, Emiliani C, Guglielmini G, et al. Platelets release their lysosomal content in vivo in humans upon activation. Thromb Haemost. 2000;83:157-164.
32. Liu Y, Kalen A, Risto O, et al. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen. 2002;10:336-340.
33. Heijnen H, Schiel A, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alphagranules. Blood. 1999;94:3791-3799.
34. Flaumenhaft R, Dilks J, Rozenvayn N, et al. The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion. Blood. 2005;105:3879-3887.
35. Junk K, Kehrel B. Platelets: physiology and biochemistry. Sem Thromb Hemost. 2005;31:381-392.
36. Roberts D, McNicol A, Bose R. Mechanism of collagen activation in human platelets. J Biol Chem. 2004;279:19421-19430.
37. Fufa D, Shealy B, Jacobson M, et al. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg. 2008;66:684-690.
38. Andrews R, Gardiner E, Asazuma N, et al. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem. 2001;276:28092-28097.
39. Pyo M, Yun-Choi H, Hong Y-J. Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines. Platelets. 2003;14:171-178.
40. Holme P, Orvim U, Hamers M, et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol. 1997;17:646-653.
41. Milovanovic M, Lysen J, Ramstrom S, et al. Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content. Thromb Res. 2003;111:75-80.
42. Italiano J, Richardson J, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008; 111:1227-1233.
43. Christgau M, Moder D, Hiller K-A, et al. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin Periodonotol. 2006;33:837-845.
44. Frechette J, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor contents and roles in wound healing. J Dent Res. 2005;84:434-439.
45. Marx R, Carlson E, Eichstaedt R, et al. Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
46. Weibrich G, Hansen T, KleisW, et al. Effect of platelet concentration in plateletrich plasma on peri-implant bone regeneration. Bone. 2004;34:665-671.
47. Ehrenfest D, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158-167.
48. Marx R. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225-228.
49. Marx R. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Res. 2004;62:489-496.
50. Anitua E, Sanchez A, Nurden A, et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24: 227-234.
51. Lopez-Vidriero E, Goulding K, Simon D, et al. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. J Arthroscopy Rel Surg. 2010;26:269-278.
52. Everts P, Mahoney C, Hoffmann J, et al. Platelet-rich plasma preparation using three devices: Implications for platelet activation and platelet growth factor release. Growth Factors. 2006;24:165-171.
53. Weibrich G, Buch R, KleisW, et al. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors. 2002;20:93-97.
54. Weibrich G, Kleis W, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Cranio- Maxillofac Surg. 2002;30:97-102.
55. Weibrich G, Kleis W, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003;14:357-362.
56. Eppley B, Woodell J, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114:1502-1508.
57. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang. 2003;85:283-289.
58. Weibrich G, Kleis W, Buch R, et al. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Comparison of a semiautomatic method with a more complex method for the preparation of platelet concentrates. Clin Oral Implants Res. 2003;14:233-239.
59. Weibrich G, Kleis W. Curasan PRP kit vs. PCCS PRP system. Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Implants Res. 2002;13:437-443.
60. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001;41:1217-1224.
61. Moojen D, Everts P, Schure R-M, et al. Antimicrobial activity of plateletleukocyte gel against Staphylococcus aureus. J Orthop Res. 2007;26: 404-410.
62. Bielecki T, Bazdzik T, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances. An in vitro study. J Bone Joint Surg Br. 2007;89-B:417-420.
63. Toumi H, Best TM. The inflammatory response: friend or enemy for muscle injury? Br J Sports Med. 2003;37:284-286.
64. Borselli C, Storrie H, Benesch-Lee F, et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci. 2010;107:3287-3292.
65. Nurden A, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21:21-36.
66. Ornitz D, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2: 1-12.
67. Schertzer J, Lynch GS. Comparative evaluation of IGF-1 gene transfer and IGF-1 protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther. 2006;13:1657-1664.
68. Roussy Y, Duchesne M-P, Gagnon G. Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res. 2007;18:639-648.
69. Hildebrand K, Woo S, Smith DJ, et al. The effects of platelet-derived growth factor-B on healing of the rabbit medial collateral ligament. An in vivo study. Am J Sports Med. 1998;26:549-554.
70. Chan B, Fu C, Qin L, et al. Supplementation-time dependence of growth factors in promoting tendon healing. Clin Orthop Relat Res. 2006;448: 240-247.
71. Huard J, Li Y, Fu F. Muscle injuries and repair: current trends in research. J Bone Joint Surg. 2002;84-A:822-833.
72. Lee JW, Harwood F, Akeson W, et al. Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments. Iowa Orthop J. 1998;18:19-25.
73. Askling C, Saartok T, Thorstensson A. Type of acute hamstring strain affects flexibility, strength, and time to return to pre-injury level. Br J Sports Med. 2006;40:40-44.
74. Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop Scand. 2006;77:806-812.
75. Landesberg R, Moses M, Karpatkin M. Risks of using platelet rich plasma gel. J Oral Maxillofac Surg. 1998;46:1116-1117.